Subscribe To

Price Alert Latest News Economic Calendar News

ELTP / Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022

Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC PINK:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that the third quarter financial results of the 2022 fiscal year will be released on Monday, February 14, 2022. Elite's management will host a live conference call Tuesday, February 15th at 11:30 AM EST to discuss the company's financial and operating results and provide a general business update. Read More

Demo Live Account See Partner Details

Content Topics

Aakash

Exploration

Services

Limited

Ns

Pharmaceuticals

Conference

Provide

Corporate

Update

Discuss

Quarter

Financial

Results

February

Stock

ELTP

Posted: Feb 9 2022, 17:15

Author Name: Accesswire

ELTP News

By InvestorPlace
October 9, 2023

Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024

When it comes to stock predictions and penny stocks to buy, admittedly the near-term picture remains cloudy. Right now, it's unclear whether high inte

By Accesswire
August 9, 2023

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023

Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / El

By Accesswire
June 29, 2023

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the

By Accesswire
June 22, 2023

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023

Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceutic

By Seeking Alpha
February 15, 2023

Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q3 2023 Earnings Conference Call February 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President

By Accesswire
February 14, 2023

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("El

By Seeking Alpha
June 30, 2022

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and

By Accesswire
June 29, 2022

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or t

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.